Kraig Biocraft Laboratories, Inc. KBLB
$0.08
$0.00-1.35%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -3.97M | -3.62M | -3.69M | -2.61M | -3.49M |
| Total Depreciation and Amortization | 89.40K | 88.90K | 136.50K | 121.60K | 91.40K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.10M | 821.80K | 821.10K | -113.50K | 768.00K |
| Change in Net Operating Assets | 896.90K | 923.80K | 877.90K | 886.60K | 847.60K |
| Cash from Operations | -1.88M | -1.79M | -1.85M | -1.72M | -1.78M |
| Capital Expenditure | -19.50K | -5.40K | -8.00K | -8.00K | -4.20K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 443.40K | 443.40K | 370.00K | 147.20K | -- |
| Cash from Investing | 424.00K | 438.10K | 362.10K | 139.30K | -4.20K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -125.00K | -125.00K | -50.00K | -5.20K | -20.20K |
| Issuance of Common Stock | 4.08M | 2.60M | 1.93M | 856.30K | 168.20K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | -10.00K | -10.00K | -10.00K | -10.00K |
| Cash from Financing | 3.95M | 2.47M | 1.87M | 841.10K | 138.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 2.49M | 1.12M | 375.60K | -736.10K | -1.65M |